Antibodies for the treatment of Clostridium difficile-associated infection and disease

Details for Australian Patent Application No. 2011239470 (hide)

Owner Progenics Pharmaceuticals, Inc.

Inventors Ma, Dangshe; Nagashima, Kirsten; Kennedy, Brian; Donovan, Gerald P.; Kang, Yun; Olson, William C.; Kumar, Shankar; Tsurushita, Naoya; Marozsan, Andre J.; Cupo, Albert

Agent Pizzeys

Pub. Number AU-A-2011239470

PCT Pub. Number WO2011/130650

Priority 61/324,503 15.04.10 US; 61/381,669 10.09.10 US

Filing date 15 April 2011

Wipo publication date 20 October 2011

International Classifications

C07K 16/12 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 31/04 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C12N 15/13 Mutation or genetic engineering - Immunoglobulins

Event Publications

1 November 2012 PCT application entered the National Phase

  PCT publication WO2011/130650 Priority application(s): WO2011/130650

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011239486-Plants with altered cell wall biosynthesis and methods of use

2011239467-Compositions and methods for characterizing a myopathy